Hutch News
Results per Page:
Dr. David Hockenbery receives the 2022 Ali Al-Johani Award
Gastroenterologist honored for his compassion and care of patients
Tip Sheet: Colorectal cancer, COVID-19 super-spreading, gene therapy for herpes, contagious cancer in Tasmanian devils – and more
Summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.
Can a tumor that acts like a microbe help us develop better cancer therapies?
Understanding the genetics underlying spontaneous regression of an infectious tumor in Tasmanian devils could point us toward new treatment targets
Fnip1 at the interplay for Polycystic kidney diseases
from the Iritani lab, Basic Sciences Division
Getting to the heart of complex cancer mutations
From the Clurman lab, Human Biology Division
Machine learning provides new insights into tumor suppression
Algorithm illuminated surprising metabolic effects of important cancer gene
Drs. Michael Emerman and Nina Salama elected to Fellowship in the American Academy of Microbiology
Celebrating faculty and staff achievements
Center awarded $11.5 million for breast cancer research consortium
Porter, Cheever will lead the five-year Seattle-based SPORE in projects including development of targeted treatments for drug-resistant tumors
Pond poison tackles tenacious cancer cells
Modified cell toxin used to control invasive fish populations may lead to drug that lowers resistance to cancer therapies
New use for a cell toxin found to inhibit survival proteins in cancer cells
Findings could lead to new drug to lower resistance to cancer therapies
Gaining gastrointestinal GVHD control
Phase III clinical trial on drug therapy to combat graft-vs.-host disease in stem-cell patients shows significant reduction in deaths
Bringing discoveries to life
New Technology Development Fund bridges funding gap, provides critical support for projects with commercial, public-benefit applications